MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$29.56
-7.54%
Mkt Cap $1.12B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.64 | -$0.49 | +23.44% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.73 | -$0.63 | +13.70% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.77 | -$0.58 | +24.68% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.81 | -$0.71 | +12.35% | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | -$0.59 | -$0.47 | +20.34% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$2.72 | -$2.78 | -2.21% | — | — |
| Q3 2024 Aug 23, 2024 | — | — | — | — | -$11.47 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.26 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.32 | — | — | — |